Prospects for specific immunotherapy in myasthenia gravis

L. Steinman,R. Mantegazza
DOI: https://doi.org/10.1096/fasebj.4.10.2197152
1990-07-01
The FASEB Journal
Abstract:Myasthenia gravis is an autoimmune disease resulting from a breakdown in T and B cell tolerance to acetylcholine receptor (AChR). Autoantibodies to AChR mediate the disease. Recent advances in experimental immunotherapy of autoimmune disease provide several possibilities for specific intervention in this well‐characterized condition.—Steinman, L.; Mantegazza, R. Prospects for specific immunotherapy in myasthenia gravis. FASEB J. 4: 2726‐2731; 1990.
What problem does this paper attempt to address?